手术切除是目前公认的治疗原发性肝细胞癌的首选治疗方法。乙型肝炎病毒感染是中国原发性肝细胞癌的主要病因。原发性肝细胞癌在手术切除后,常出现乙型肝炎病毒再激活而影响肿瘤的复发及治疗效果,继而影响患者的远期生存。因此,抗病毒治疗在乙型肝炎病毒相关原发性肝细胞癌手术切除中的应用十分重要,能够减少病毒再激活,减轻肝损害,提高治疗效果。 Surgical resection is currently recognized as the preferred treatment for primary hepatocellular carcinoma. Hepatitis B virus infection is the main cause of primary hepatocellular carcinoma in China. Primary hepatocellular carcinoma after surgical resection, often re-activation of hepatitis B virus affect the recurrence and treatment of tumors, which in turn affect the long-term survival of patients. Therefore, antiviral therapy in hepatitis B virus-related primary hepatocellular carcinoma surgery is very important to reduce the reactivation of the virus, reduce liver damage and improve the therapeutic effect.